Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.24M | 57.79M | 55.40M | 55.24M | 55.13M |
| Total Other Revenue | 619.00K | 1.61M | 1.00M | 1.00M | 1.00M |
| Total Revenue | 61.86M | 59.40M | 56.40M | 56.24M | 56.13M |
| Cost of Revenue | 20.92M | 20.16M | 18.88M | 19.67M | 20.88M |
| Gross Profit | 40.93M | 39.24M | 37.52M | 36.58M | 35.25M |
| SG&A Expenses | 44.37M | 44.57M | 43.91M | 42.35M | 40.20M |
| Depreciation & Amortization | 4.26M | 4.17M | 3.92M | 3.67M | 3.42M |
| Other Operating Expenses | -- | -4.55M | -4.55M | -4.55M | -4.55M |
| Total Operating Expenses | 70.03M | 64.89M | 63.26M | 63.15M | 69.81M |
| Operating Income | -8.17M | -5.50M | -6.86M | -6.91M | -13.68M |
| Income Before Tax | -11.37M | -8.54M | -8.62M | -8.24M | -14.61M |
| Income Tax Expenses | 60.00K | 121.00K | 121.00K | 61.00K | 61.00K |
| Earnings from Continuing Operations | -11.43 | -8.66 | -8.74 | -8.30 | -14.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.43M | -8.66M | -8.74M | -8.30M | -14.67M |
| EBIT | -8.17M | -5.50M | -6.86M | -6.91M | -13.68M |
| EBITDA | -3.91M | -1.32M | -2.94M | -3.24M | -10.25M |
| EPS Basic | -0.48 | -0.36 | -0.39 | -0.39 | -0.74 |
| Normalized Basic EPS | -0.30 | -0.22 | -0.27 | -0.28 | -0.50 |
| EPS Diluted | -0.48 | -0.36 | -0.39 | -0.39 | -0.74 |
| Normalized Diluted EPS | -0.30 | -0.22 | -0.27 | -0.28 | -0.50 |
| Average Basic Shares Outstanding | 97.97M | 92.17M | 87.75M | 84.45M | 81.60M |
| Average Diluted Shares Outstanding | 97.97M | 92.17M | 87.75M | 84.45M | 81.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |